ConductScience.org, home

Trial · NCT01633398

ASIAN HF Registry, A Prospective Observational Study

NCT01633398, Completed, Carolyn Lam; results first posted 2021-07-14

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. ASIAN HF Registry, A Prospective Observational Study. Trials, record NCT01633398. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01633398

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
ASIAN HF Registry, A Prospective Observational Study
NCT number
NCT01633398
Status
Completed
Enrollment
6,329 participants, actual
Lead sponsor
Carolyn Lam
Conditions
Heart Failure
Interventions
Saliva Genetic testing
First posted
2012-07-04
Last updated
2021-07-14
Results first posted
2021-07-14

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryAll Cause and Cause-specific Death2 years follow upThe incidence of all-cause and cause-specific deaths among Asian patients with HF.
SecondarySudden Cardiac Death2 years follow upThe incidence of sudden cardiac death (SCD) in eligible Asian patients diagnosed with HFrEF

Outcomes2

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYAll Cause and Cause-specific Death2 years follow upPatients with outcomes available at 1 year were examined for all-cause and cardiovascular (CV) death. Patients who were lost to follow-up were excluded from the analysis.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYSudden Cardiac Death2 years follow up
ESC guidelines recommend an implantable cardioverter-defibrillator (ICD) device for primary prevention in symptomatic patients with heart failure with reduced ejection fraction (HFrEF), provided they are expected to survive substantially longer than one year with good functional status.~For this outcome measure, only HFrEF patients who were eligible for ICD devices were included; HFpEF patients were excluded.
ParticipantsCOUNT_OF_PARTICIPANTS

Results by group6

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
All Cause and Cause-specific DeathHFrEFAll-cause mortality500Participants
All Cause and Cause-specific DeathHFpEFAll-cause mortality60Participants
All Cause and Cause-specific DeathHFrEFCV mortality270Participants
All Cause and Cause-specific DeathHFpEFCV mortality32Participants
Sudden Cardiac DeathHFrEF109Participants
Sudden Cardiac DeathHFpEF0Participants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDHFrEF4,779
Overall StudySTARTEDHFpEF1,550
Overall StudyCOMPLETEDHFrEF4,779
Overall StudyCOMPLETEDHFpEF1,550
Overall StudyNOT COMPLETEDHFrEF0
Overall StudyNOT COMPLETEDHFpEF0

Adverse events2

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
seriousDeathCardiac disordersHFrEF5004,737500
seriousDeathCardiac disordersHFpEF601,11460

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityHFrEF5004,737
Total, all-cause mortalityHFpEF601,114
Total, other adverse eventsHFrEF00
Total, other adverse eventsHFpEF00
Total, serious adverse eventsHFrEF5004,737
Total, serious adverse eventsHFpEF601,114

Papers18

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
12860859BACKGROUNDPubMed
19358937BACKGROUNDPubMed
23568645DERIVEDPubMed
27502121DERIVEDPubMed
29150533DERIVEDPubMed
29584721DERIVEDPubMed
30103979DERIVEDPubMed
30548089DERIVEDPubMed
31292141DERIVEDPubMed
31431116DERIVEDPubMed

1 to 10 of 18

See all 18 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons2

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
HFrEF vs HFpEF: deaths from any causeTrial comparisons
HFrEF vs HFpEF: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Source

Release
trials-2026-11-12-0.4.0
Release manifest SHA-256
0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
Registry capture
2026-11-12
Results copy, AACT
2026-03-23
NIH clinical studies file
2026-11-13

Source ClinicalTrials.gov

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01633398

GET https://conductscience.org/api/trials/v1/NCT01633398/registered